Focus Partners Advisor Solutions’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Focus Partners Advisor Solutions's LLY Position: Q2 2026 in Review
Focus Partners Advisor Solutions reduced its Eli Lilly (LLY) stake by 8.2% in Q2 2026, selling an estimated $1.28M and leaving 13,987 shares worth $16.8M. The position accounts for 0.14% of the portfolio, ranked #79.
Focus Partners Advisor Solutions first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. The position peaked at $17.5M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Focus Partners Advisor Solutions held 13,987 shares of Eli Lilly worth $16.8M as of Q2 2026.
- Focus Partners Advisor Solutions sold 1,254 Eli Lilly shares in Q2 2026, an estimated $1.28M.
- Eli Lilly made up 0.14% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #79 holding.
- Focus Partners Advisor Solutions first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
- Focus Partners Advisor Solutions's Eli Lilly position peaked at $17.5M in Q4 2025.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.